Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICEBERG: Intracoronary Darbepoetin-alpha in STEMI
NCT01538771Phase 2Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Nov 2009
- Primary completion
- Sep 2012
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of darbepoetin alfa in myocardial infarction (MI), sponsored by Seoul National University Bundang Hospital. Started Nov 2009; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01538771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538771.